Dissociation in the recovery from neglect dyslexia and visuospatial unilateral neglect: a case report

The recovery of the ability to read of a patient affected by persistent visuospatial neglect suggests the functional independence of the two phenomena. Neglect dyslexia seems to be an example of a dissociation between an implicit and explicit knowledge of the characteristics of the stimulus.

---

Sommario Il recupero della capacità di lettura in un paziente con persistente neglect visuo-spaziale suggerisce l'indipendenza funzionale dei due fenomeni. La neglect dyslexia sembra costituire un esempio di dissociazione tra conoscenza implicita ed esplicita delle caratteristiche dello stimolo.

     

Experimental wax mixtures for dental use

summary Improvements in the properties of dental waxes were sought by alterations in their composition. Twenty-six blends of paraffin wax, beeswax and inorganic filler were subjected to the following tests: plastic deformation (flow), linear thermal expansion, elastic modulus and flexural strength. Flow tests were conducted in accordance with the corresponding ISO specification, Thermal expansion coefficients were estimated using thermomechanical analysis. Mechanical properties were tested using a universal testing machine. Pure paraffin and beeswax were used as controls. The results were subjected to analysis using correlation and regression. Regression coefficients in the range of 0.90–0.99 were obtained in most cases, flow tests exhibiting the highest coefficients and flexural strength the lowest. The incorporated filler particles reduced the flow of the natural waxes, especially of the ester-containing beeswax, and improved the elastic modulus and strength. Good correlation was found between the ingredient proportions and measured properties, suggesting a relationship between them, although this is quite complicated in the case of tertiary wax mixtures. The experimental blends exhibited properties that are potentially useful for a range of clinical applications.     

A randomized controlled trial of antibiotics on symptom resolution in patients presenting to their general practitioner with a sore throat.

BACKGROUND: Sore throat is a common symptom presented to general practitioners (GPs), and there remains controversy about the appropriate use of antibiotics. AIM: To compare, in a randomized controlled trial, the effectiveness of penicillin, cefixime and placebo on symptom resolution in patients presenting with a sore throat in general practice. METHOD: Twenty-two GPs in Avon recruited 154 patients, aged 16-60 years, presenting to their GP with a sore throat, and for whom the GP would normally prescribe an antibiotic. Patients were randomized to one of three groups: penicillin V 250 mg four times a day; cefixime 200 mg daily; and placebo. Each was prescribed for five days. The main outcome measures were a diary of symptom resolution over seven days and eradication of group A beta-haemolytic streptococcus (GABHS). RESULTS: Of the 103 (67%) patients who completed symptom diaries, 40 were allocated to receive penicillin, 29 cefixime and 34 placebo. In the analysis including all patients, symptom resolution was greater by day 3 in the cefixime group than in the placebo group. Penicillin did not improve symptom resolution by day 3 compared with placebo, and cefixime was not statistically significantly different from penicillin. There were significant differences in the proportion of patients using analgesia at day 3, with the proportion being lowest in the cefixime group. The results for the subgroup of patients without GABHS were similar to those for all patients; in particular, the only statistically significant difference was between cefixime and placebo. Although numbers were too small for statistical significance, among patients with GABHS the effects of penicillin and cefixime were similarly raised in relation to placebo. CONCLUSION: Compared with placebo, cefixime can improve the rate of resolution of symptoms in patients with a sore throat who are selected for antibiotic treatment by their GP. The unexpected finding that cefixime was of benefit compared with placebo for patients without GABHS suggests that bacteria other than GABHS may be important in the pathogenesis of sore throat.     

Prospective study of antigenemia,plasma viremia and lymphocytic viremia in HIV-infected hemophiliacs

A total of 186 blood samples from 24 HIV-1 seropositive hemophiliac patients, monitored every four months for 29 months, were investigated for the presence of viral antigen in plasma. In addition, peripheral blood mononuclear cells (PBMC) were cultured for HIV-1, using normal PBMC as a target for replication. Antigenemia was detected in 51 % of the patients and from PBMC in 87.5 % of the patients. The incidence of HIV isolation in asymptomatic patients (42.8 %) was similar to that found in symptomatic patients (51.4 %). Patients with opportunistic infections had a higher incidence of lymphocytic viremia (p<0.05). Plasma viremia was closely associated (p<0.05) with low CD4+ counts and infection progression. The persistence of antigenemia was also a marker of a poor clinical course. In treated patients, plasma viremia was the marker that better correlated with the clinical course, and it did not appear during the first nine months of therapy. Zidovudine doses of >500 mg/day significantly lowered the appearance of antigenemia and lymphocytic viremia (p<0.05).